Trials / Conditions / Multiple Myeloma With Failed Remission
Multiple Myeloma With Failed Remission
5 registered clinical trials studyying Multiple Myeloma With Failed Remission.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma NCT05673083 | All4Cure | — |
| Active Not Recruiting | Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001) NCT04184050 | Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 1 |
| Completed | A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) NCT03650491 | Fortis Therapeutics, Inc. | Phase 1 |
| Unknown | Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma NCT03428373 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Phase 2 / Phase 3 |
| Terminated | Tinostamustine Conditioning and Autologous Stem Cell NCT03687125 | Mundipharma-EDO GmbH | Phase 1 / Phase 2 |